Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2006

Aug 29, 2006

30339_dirs_2006-08-29_1af77dd8-b6ab-49f2-97a3-53acad7efd0f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC ((WST))
CIK: 0000105770
Period of Report: 2006-08-25

Reporting Person: MOREL DONALD E JR (Chair of the Board & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2006-08-23 Common Stock G 3300 Disposed 213059.4743 Direct
2006-08-25 Common Stock M 46596 $14.7032 Acquired 259655.4743 Direct
2006-08-25 Common Stock M 22196 $13.9925 Acquired 281851.4743 Direct
2006-08-25 Common Stock M 44065 $11.2950 Acquired 325916.4743 Direct
2006-08-25 Common Stock F 29461 $38.6100 Disposed 296455.4743 Direct
2006-08-25 Common Stock F 13791 $13.9925 Disposed 282664.4743 Direct
2006-08-25 Common Stock F 25551 $11.2950 Disposed 257113.4743 Direct
2006-08-25 Common Stock A 20.39 $38.2000 Acquired 14776.9675 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2006-08-25 Stock Option (Right to Buy) $14.7032 M 46596 Disposed 2007-08-05 Common Stock (46596.00) Direct
2006-08-25 Stock Option (Right to Buy) $11.2950 M 44065 Disposed 2008-04-28 Common Stock (44065.00) Direct
2006-08-25 Stock Option (Right to Buy) $13.9925 M 22196 Disposed 2012-04-30 Common stocks (22196.00) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 780.5432 Indirect

Footnotes

F1: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.